(Q38098265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Ketamine as a fast acting antidepressant: current knowledge and open questions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Giacomo Salvadore

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jaskaran B Singh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

1 reference

12 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

428-436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

28 February 2020

cites work

1 reference

Synaptic mechanisms underlying rapid antidepressant action of ketamine

21 January 2018

1 reference

Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder.

21 January 2018

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

21 January 2018

1 reference

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

21 January 2018

1 reference

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

21 January 2018

1 reference

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

21 January 2018

1 reference

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

21 January 2018

1 reference

Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

21 January 2018

1 reference

21 January 2018

Ketamine use: a review

1 reference

Adverse events associated with ketamine for procedural sedation in adults

21 January 2018

1 reference

Psychiatric safety of ketamine in psychopharmacology research

21 January 2018

1 reference

Acute and chronic effects of ketamine upon human memory: a review

21 January 2018

1 reference

Synaptic dysfunction in depression: potential therapeutic targets

21 January 2018

1 reference

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

21 January 2018

1 reference

In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia

21 January 2018

1 reference

Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study

21 January 2018

1 reference

Glutamatergic modulators: the future of treating mood disorders?

21 January 2018

1 reference

¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism

21 January 2018

1 reference

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

21 January 2018

1 reference

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex

21 January 2018

1 reference

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

21 January 2018

1 reference

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

21 January 2018

1 reference

The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders

21 January 2018

1 reference

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

21 January 2018

1 reference

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

21 January 2018

1 reference

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.

21 January 2018

1 reference

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

21 January 2018

1 reference

A direct demonstration of cortical LTP in humans: a combined TMS/EEG study

21 January 2018

1 reference

Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity

21 January 2018

1 reference

Ketamine increases human motor cortex excitability to transcranial magnetic stimulation

21 January 2018

1 reference

Neural circuits underlying the pathophysiology of mood disorders

21 January 2018

1 reference

Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus

21 January 2018

1 reference

Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression.

21 January 2018

1 reference

Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers.

21 January 2018

1 reference

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action

21 January 2018

1 reference

Two views of brain function

21 January 2018

1 reference

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

21 January 2018

1 reference

Targeted electrode-based modulation of neural circuits for depression

21 January 2018

1 reference

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

21 January 2018

1 reference

Limbic over-activity in depression during preserved performance on the n-back task

21 January 2018

1 reference

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression

21 January 2018

1 reference

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

21 January 2018

1 reference

Sleep function and synaptic homeostasis

21 January 2018

1 reference

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23578128

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CNS.12103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23578128%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

23578128

1 reference